Insider · CIK 0001679966

Grant Grady III

Reports to the SEC for 1 company · SEATTLE, WA

sec.gov

Transactions

Companies

Filings

CIK

0001679966

Forms 4 and 5

Insider transactions

32 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-06	APVOAptevo Therapeutics Inc. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−400 sh	—	—	0
2026-08-06	APVOAptevo Therapeutics Inc.M Exercise/Conversion	Director	MExercise/Conversion	+400 sh	—	—	1,150
2025-11-10	APVOAptevo Therapeutics Inc.P Purchase	Director	PPurchase	+13.5K sh	$1.49	+$20.1K	13,514
2025-08-06	APVOAptevo Therapeutics Inc. · Restricted Stock UnitA Award	Director	AAward	+7,200 sh	—	—	7,200
2025-07-17	APVOAptevo Therapeutics Inc. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−1 sh	—	—	0
2025-07-17	APVOAptevo Therapeutics Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1 sh	—	—	1
2024-07-17	APVOAptevo Therapeutics Inc. · Restricted Stock UnitA Award	Director	AAward	+925 sh	—	—	925
2024-06-02	APVOAptevo Therapeutics Inc. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−81 sh	—	—	0
2024-06-02	APVOAptevo Therapeutics Inc.M Exercise/Conversion	Director	MExercise/Conversion	+81 sh	—	—	198
2024-06-01	APVOAptevo Therapeutics Inc. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−7 sh	—	—	0
2024-06-01	APVOAptevo Therapeutics Inc.M Exercise/Conversion	Director	MExercise/Conversion	+7 sh	—	—	117
2023-08-09	APVOAptevo Therapeutics Inc.M Exercise/Conversion	Director	MExercise/Conversion	+3,571 sh	—	—	4,880
2023-08-09	APVOAptevo Therapeutics Inc. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−3,571 sh	—	—	0
2023-06-02	APVOAptevo Therapeutics Inc. · Restricted Stock UnitA Award	Director	AAward	+3,571 sh	—	—	3,571
2023-06-01	APVOAptevo Therapeutics Inc.M Exercise/Conversion	Director	MExercise/Conversion	+297 sh	—	—	1,309
2023-06-01	APVOAptevo Therapeutics Inc. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−297 sh	—	—	298
2022-08-09	APVOAptevo Therapeutics Inc. · Restricted Stock UnitA Award	Director	AAward	+3,571 sh	—	—	3,571
2022-06-01	APVOAptevo Therapeutics Inc.M Exercise/Conversion	Director	MExercise/Conversion	+298 sh	—	—	1,012
2022-06-01	APVOAptevo Therapeutics Inc. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−298 sh	—	—	595
2021-06-01	APVOAptevo Therapeutics Inc. · Restricted Stock UnitA Award	Director	AAward	+893 sh	—	—	893
2021-06-01	APVOAptevo Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+2,678 sh	—	—	2,678
2020-07-27	APVOAptevo Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+1,322 sh	—	—	1,322
2020-07-27	APVOAptevo Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+170 sh	—	—	170
2020-07-27	APVOAptevo Therapeutics Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,785 sh	—	—	0
2020-07-27	APVOAptevo Therapeutics Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−892 sh	—	—	0
2020-07-27	APVOAptevo Therapeutics Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,339 sh	—	—	0
2020-07-02	APVOAptevo Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+3,571 sh	—	—	3,571
2019-06-01	APVOAptevo Therapeutics Inc. · Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2019-05-21	APVOAptevo Therapeutics Inc.P Purchase	Director	PPurchase	+10K sh	$0.80	+$7,970	10,000
2018-06-01	APVOAptevo Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2017-06-01	APVOAptevo Therapeutics Inc. · Employee Stock Option (right to buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2016-08-03	APVOAptevo Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+18.8K sh	—	—	18,750

Recent filings

Accepted (ET)
Aug 104
Grant Grady III0001193125-26-343072
SEC(opens sec.gov)
Nov 124
Grant Grady III0001193125-25-277771
SEC(opens sec.gov)
Aug 84
Grant Grady III0000950170-25-105936
SEC(opens sec.gov)
Jul 214
Grant Grady III0000950170-25-097278
SEC(opens sec.gov)
Jul 194
Grant Grady III0000950170-24-084954
SEC(opens sec.gov)
Jun 34
Grant Grady III0000950170-24-068067
SEC(opens sec.gov)
Aug 104
Grant Grady III0001209191-23-045298
SEC(opens sec.gov)
Jun 24
Grant Grady III0001209191-23-033846
SEC(opens sec.gov)
Aug 104
Grant Grady III0001209191-22-045193
SEC(opens sec.gov)
Jun 34
Grant Grady III0001209191-22-033920
SEC(opens sec.gov)
Jun 24
Grant Grady III0001019056-21-000356
SEC(opens sec.gov)

Companies

Aptevo Therapeutics Inc.DirectorAPVO

Address

2401 4TH AVENUE SUITE 1050

SEATTLE, WA, 98121